The data thus far is impressive. Hopefully the next trial will follow suit and build on the momentum from the higher dose as it reaches PR quite swiftly >30% relief in tumor burden. Optimistic they have something special here. Time will tell and think also the US trial will really be a massive value creator with their different SOC. Other targets as well!
The data thus far is impressive. Hopefully the next trial will...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $114.3M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 22.5¢ | $1.376M | 5.902M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 171285 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 1115446 | 12 |
View Market Depth
| Last trade - 12.34pm 30/07/2025 (20 minute delay) ? |
| ATX (ASX) Chart |